Ali J. Satvat serves as Executive at Eidos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ali J. Satvat has executed 12 insider transactions totaling $116.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 3, 2019 involved purchasing 882,353 shares valued at $26.4M.
Ali J. Satvat currently holds 24,575,501 shares of Eidos Therapeutics, Inc. (EIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ali J. Satvat has been a net buyer of EIDX stock. They have purchased $116.2M and sold $0 worth of shares.
Ali J. Satvat's most recent insider trade was on Jul 3, 2019, when they purchased 882,353 shares at $29.90 per share.
Get notified when new Form 4 filings are submitted
| $25.93 |
| Discretionary |
| Dec 10, 2018 | EIDX | $504.9K | Purchase | 37,989 | $13.29 | Discretionary |
| Dec 10, 2018 | EIDX | $37.2K | Purchase | 2,664 | $13.96 | Discretionary |
| Dec 7, 2018 | EIDX | $506.2K | Purchase | 36,314 | $13.94 | Discretionary |
| Dec 7, 2018 | EIDX | $69.8K | Purchase | 4,860 | $14.36 | Discretionary |
| Dec 6, 2018 | EIDX | $519.9K | Purchase | 38,970 | $13.34 | Discretionary |
| Dec 5, 2018 | EIDX | $15.5M | Purchase | 1,103,848 | $14.01 | Discretionary |
| Dec 3, 2018 | EIDX | $27.1M | Purchase | 1,750,000 | $15.50 | Discretionary |
| Jun 22, 2018 | EIDX | $0 | Conversion | 18,826,417 | $N/A | Discretionary |
| Jun 22, 2018 | EIDX | $3.6M | Payment | 211,762 | $17.00 | Discretionary |
| Jun 22, 2018 | EIDX | $17.0M | Purchase | 1,000,000 | $17.00 | Discretionary |